Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Pediatrics,
Division of Cellular and Molecular Therapy,
Department of Pediatrics, Division of Cellular and Molecular Therapy
Wenqin Ma has not added Biography.
If you are Wenqin Ma and would like to personalize this page please email our Author Liaison for assistance.
Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity.
Human gene therapy Feb, 2007 | Pubmed ID: 17328683
High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy.
Human gene therapy Nov, 2010 | Pubmed ID: 20507237
Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3.
Human gene therapy Dec, 2010 | Pubmed ID: 20545554
High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines.
Molecular therapy : the journal of the American Society of Gene Therapy Dec, 2010 | Pubmed ID: 20736929
A simple method to increase the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo.
Human gene therapy May, 2011 | Pubmed ID: 21219084
University of Florida
Chen Ling1,
Yuan Lu1,
Binbin Cheng1,
Katherine E. McGoogan1,
Samantha W.Y. Gee1,
Wenqin Ma1,
Baozheng Li1,
George V. Aslanidi1,
Arun Srivastava1
1Department of Pediatrics, Division of Cellular and Molecular Therapy, University of Florida
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.